accountKing Pharmaceuticals (KG) was upgraded today by analysts at Thomson Financial - Gradient and the stock is now at $12.31, down $0.13 (-1.05%) on...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to King Pharmaceuticals (KG) Down Over 1% Following Broker Upgrade
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account